This company provides an AI-driven platform for analyzing bone marrow morphology to enhance blood cancer insights. The platform quantifies established markers and uncovers novel morphological patterns predictive of clinical outcomes. It allows researchers and clinicians to contextualize findings against curated patient cohorts using standard-of-care slides.
Funding
$4.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Analyzing bone marrow tissue morphology to understand blood cancer biology is a complex process that traditionally relies on manual review, which can be subjective, time-consuming, and prone to variability. Identifying subtle morphological patterns predictive of clinical outcomes requires specialized expertise and can be challenging to scale across diverse patient cohorts.
Solution
Ground Truth Labs offers an AI-driven platform that automates the analysis of bone marrow tissue morphology, quantifying key features and identifying novel patterns predictive of clinical outcomes. The platform utilizes machine learning and computer vision to analyze standard-of-care slides, eliminating the need for special staining or data modifications. By providing an integrated suite of AI models, the platform streamlines analysis, enhances reproducibility, and unlocks new insights for clinical and research applications. The platform also allows users to contextualize findings within curated patient cohorts, enabling cross-cohort comparisons and a deeper understanding of disease variability.
Target Audience
The primary users are researchers, clinicians, and pharmaceutical companies involved in blood cancer research and treatment.
Features
- AI models for quantifying morphology in bone marrow tissue at both the slide and cell levels
- Identification of key features such as fibrosis, megakaryocytes, blasts, and plasma cells
- AI-driven discovery platform to uncover novel morphological patterns predictive of clinical outcomes
- Ability to compare results across diverse patient cohorts
- Compatibility with standard-of-care slides, eliminating the need for special staining